194 related articles for article (PubMed ID: 19963078)
21. Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene.
Bhuju S; Fonseca Lde S; Marsico AG; de Oliveira Vieira GB; Sobral LF; Stehr M; Singh M; Saad MH
Infect Genet Evol; 2013 Oct; 19():1-6. PubMed ID: 23770140
[TBL] [Abstract][Full Text] [Related]
22. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from northwestern Russia.
Marttila HJ; Marjamäki M; Vyshnevskaya E; Vyshnevskiy BI; Otten TF; Vasilyef AV; Viljanen MK
Antimicrob Agents Chemother; 1999 Jul; 43(7):1764-6. PubMed ID: 10390239
[TBL] [Abstract][Full Text] [Related]
23. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal.
Portugal I; Barreiro L; Moniz-Pereira J; Brum L
Antimicrob Agents Chemother; 2004 Jul; 48(7):2736-8. PubMed ID: 15215139
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide.
Petrella S; Gelus-Ziental N; Maudry A; Laurans C; Boudjelloul R; Sougakoff W
PLoS One; 2011 Jan; 6(1):e15785. PubMed ID: 21283666
[TBL] [Abstract][Full Text] [Related]
25. Computational discovery of potent drugs to improve the treatment of pyrazinamide resistant Mycobacterium tuberculosis mutants.
Jagadeb M; Rath SN; Sonawane A
J Cell Biochem; 2018 Sep; 119(9):7328-7338. PubMed ID: 29761826
[TBL] [Abstract][Full Text] [Related]
26. Pyrazinamide resistance associated with pncA gene mutation in Mycobacterium tuberculosis in Japan.
Endoh T; Yagihashi A; Uehara N; Kobayashi D; Tsuji N; Nakamura M; Hayashi S; Fujii N; Watanabe N
Epidemiol Infect; 2002 Apr; 128(2):337-42. PubMed ID: 12002553
[TBL] [Abstract][Full Text] [Related]
27. Rapid detection of pyrazinamide-resistant Mycobacterium tuberculosis by a PCR-based in vitro system.
Suzuki Y; Suzuki A; Tamaru A; Katsukawa C; Oda H
J Clin Microbiol; 2002 Feb; 40(2):501-7. PubMed ID: 11825963
[TBL] [Abstract][Full Text] [Related]
28. Biochemical Characterization and Computational Identification of Mycobacterium tuberculosis Pyrazinamidase in Some Pyrazinamide-Resistant Isolates of Iran.
Doustdar F; Pazhang M; Mehrnejad F; Safarzadeh M; Rabiei D; Chaparzadeh N; Falahati H; Mir-Derikvand M
Protein J; 2015 Jun; 34(3):181-92. PubMed ID: 25972249
[TBL] [Abstract][Full Text] [Related]
29. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.
Lee KW; Lee JM; Jung KS
J Korean Med Sci; 2001 Oct; 16(5):537-43. PubMed ID: 11641519
[TBL] [Abstract][Full Text] [Related]
30. Analysis of mutations in pncA reveals non-overlapping patterns among various lineages of Mycobacterium tuberculosis.
Baddam R; Kumar N; Wieler LH; Lankapalli AK; Ahmed N; Peacock SJ; Semmler T
Sci Rep; 2018 Mar; 8(1):4628. PubMed ID: 29545614
[TBL] [Abstract][Full Text] [Related]
31. Drug resistance mechanism of PncA in Mycobacterium tuberculosis.
Rajendran V; Sethumadhavan R
J Biomol Struct Dyn; 2014; 32(2):209-21. PubMed ID: 23383724
[TBL] [Abstract][Full Text] [Related]
32. Structure guided prediction of Pyrazinamide resistance mutations in pncA.
Karmakar M; Rodrigues CHM; Horan K; Denholm JT; Ascher DB
Sci Rep; 2020 Feb; 10(1):1875. PubMed ID: 32024884
[TBL] [Abstract][Full Text] [Related]
33. Study of pyrazinamidase structural changes in pyrazinamide resistant and susceptible isolates of Mycobacterium tuberculosis.
Ahmady A; Poolad T; Rafee P; Tousheh M; Kahbazi M; Arjomandzadegan M
Tuberk Toraks; 2013; 61(2):110-4. PubMed ID: 23875588
[TBL] [Abstract][Full Text] [Related]
34. Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan.
Ando H; Mitarai S; Kondo Y; Suetake T; Sekiguchi JI; Kato S; Mori T; Kirikae T
Clin Microbiol Infect; 2010 Aug; 16(8):1164-8. PubMed ID: 19832709
[TBL] [Abstract][Full Text] [Related]
35. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.
Singh P; Mishra AK; Malonia SK; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM
J Commun Dis; 2006 Mar; 38(3):288-98. PubMed ID: 17373362
[TBL] [Abstract][Full Text] [Related]
36. [Studies on pncA gene mutations in M. tuberculosis isolates].
Wu X; Zhang J; Zhong M
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jan; 23(1):40-2. PubMed ID: 11778181
[TBL] [Abstract][Full Text] [Related]
37. [Characteristics of pncA gene in multidrug-resistant Mycobacterium tuberculosis isolates and its correlation with drug resistance to pyrazinamide].
Hong CY; Wang F; Gui J; Liu XL
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 May; 46(5):436-9. PubMed ID: 22883731
[TBL] [Abstract][Full Text] [Related]
38. Non-
Werngren J; Alm E; Mansjö M
J Clin Microbiol; 2017 Jun; 55(6):1920-1927. PubMed ID: 28404681
[TBL] [Abstract][Full Text] [Related]
39. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis.
Davies AP; Billington OJ; McHugh TD; Mitchison DA; Gillespie SH
J Clin Microbiol; 2000 Oct; 38(10):3686-8. PubMed ID: 11015384
[TBL] [Abstract][Full Text] [Related]
40. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey.
Yüksel P; Tansel O
New Microbiol; 2009 Apr; 32(2):153-8. PubMed ID: 19579692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
